Clinically silent somatotroph adenomas are common

European Journal of Endocrinology

Volumn 165, Issue 1, 2011, Pages 39-44

  Wade, Alisha N ^a,b   Baccon, Jennifer ^a,c   Grady, M Sean ^a   Judy, Kevin D ^a   O'Rourke, Donald M ^a   Snyder, Peter J ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPEPTIN; SOMATOMEDIN C; GLYCOPROTEIN; TUMOR MARKER;

ACROMEGALY; ACTH SECRETING ADENOMA; AGED; ARTICLE; BRAIN SURGERY; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GONADOTROPH ADENOMA; GROWTH HORMONE SECRETING ADENOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NULL CELL ADENOMA; PRIORITY JOURNAL; PROLACTINOMA; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; THYROTROPIN SECRETING ADENOMA; TUMOR CLASSIFICATION; ACTH SECRETING CELL; ADULT; CLINICAL ARTICLE; GONADOTROPIN SECRETING CELL; GROWTH HORMONE SECRETING CELL; HISTOPATHOLOGY; HYPOPHYSIS CELL; PROLACTIN SECRETING CELL; TSH SECRETING CELL; ADENOMA; METABOLISM; MIDDLE AGED; PATHOLOGY;

ACROMEGALY; ADENOMA; ADULT; AGED; FEMALE; GROWTH HORMONE-SECRETING PITUITARY ADENOMA; HUMANS; IMMUNOHISTOCHEMISTRY; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SOMATOTROPHS;

EID: 79959464194     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-11-0216     Document Type: Article

References (17)

1. Abe T, Taniyama M, Xu B, Ozawa H, Kawamura N, Shimazu M, Sasaki K, Izumiyama H, Kushima M, Kuwazawa J, Sano T & Matsumoto K. Silent mixed corticotroph and somatotroph macroadenomas presenting with pituitary apoplexy. Acta Neuropathologica 2001 102 435-440. (doi:10.1007/s004010100396)
2. Kovacs K, Lloyd R, Horvath E, Asa SL, Stefaneanu L, Killinger DW & Smyth HS. Silent somatotroph adenomas of the human pituitary. A morphologic study of three cases including immunocytochemistry, electron microscopy, in vitro examination, and in situ hybridization. American Journal of Pathology 1989 134 345-353. (Pubitemid 19063890)
3. Mohammed S, Syro L, Abad V, Salehi F, Horvath E, Scheithauer BW, Kovacs K & Cusimano M. Silent somatotroph adenoma of the pituitary in an adolescent. Canadian Journal of Neurological Sciences 2009 36 123-125.
4. Naritaka H, Kameya T, Sato Y, Furuhata S, Otani M & Kawase T. Morphological characterization and subtyping of silent somatotroph adenomas. Pituitary 1999 1 233-241. (doi:10.1023/A:1009942122673)
5. Trouillas J, Sassolas G, Loras B, Velkeniers B, Raccurt M, Chotard L, Berthezene F, Tourniaire J & Girod C. Somatotropic adenomas without acromegaly. Pathology, Research and Practice 1991 187 943-949.
6. Kalavalapalli S, Reid H, Kane J, Buckler H, Trainer P& Heald AH. Silent growth hormone secreting pituitary adenomas: IGF-1 is not sufficient to exclude growth hormone excess. Annals of Clinical Biochemistry 2007 44 89-93. (doi:10.1258/000456307779596075)
7. Klibanski A, Zervas NT, Kovacs K & Ridgway EC. Clinically silent hypersecretion of growth hormone in patients with pituitary tumors. Journal of Neurosurgery 1987 66 806-811. (doi:10.3171/jns.1987.66.6.0806)
8. Matsuno A, Ogino Y, Katayama H, Osamura RY & Nagashima T. Identification of a silent pituitary somatotropic adenoma based on a paradoxic response of growth hormone on a thyrotropinreleasing hormone or gonadotropin-releasing hormone provocation test. American Journal of Obstetrics and Gynaecology 2001 184 286-288. (doi:10.1067/mob.2001.109396)
9. Pestell R, Herington A, Best J, Boolell M, McKelvie P, Arnott R & Alford F. Growth hormone excess and galactorrhoea without acromegalic features. Case reports. British Journal of Obstetrics and Gynaecology 1991 98 92-97. (doi:10.1111/j.1471-0528.1991.tb10317.x)
10. Sakharova AA, Dimaraki EV, Chandler WF & Barkan AL. Clinically silent somatotropinomas may be biochemically active. Journal of Clinical Endocrinology and Metabolism 2005 90 2117-2121. (doi:10.1210/jc.2004-0875)
11. Sen O, Ertorer ME, Aydin MV, Erdogan B, Altinors N, Zorludemir S & Guvener N. Silent pituitary macroadenoma co-secreting growth hormone and thyroid stimulating hormone. Journal of Clinical Neuroscience 2005 12 318-320. (doi:10.1016/j.jocn.2004.05.011)
12. Sidhaye A, Burger P, Rigamonti D & Salvatori R. Giant somatotrophinoma without acromegalic features: more "quiet" than "silent": case report. Neurosurgery 2005 56 E1154. (doi:10. 1227/01.NEU.0000157961.67867.E5)
13. Tourniaire J, Trouillas J, Chalendar D, Bonneton-Emptoz A, Goutelle A & Girod C. Somatotropic adenoma manifested by galactorrhea without acromegaly. Journal of Clinical Endocrinology and Metabolism 1985 61 451-453. (doi:10.1210/jcem-61-3-451)
14. Yamada S, Sano T, Stefaneanu L, Kovacs K, Aiba T, Sawano S & Shishiba Y. Endocrine and morphological study of a clinically silent somatotroph adenoma of the human pituitary. Journal of Clinical Endocrinology and Metabolism 1993 76 352-356. (doi:10.1210/jc.76.2.352)
15. Obari A, Sano T, Ohyama K, Kudo E, Qian ZR, Yoneda A, Rayhan N, Mustafizur Rahman M & Yamada S. Clinicopathological features of growth hormone-producing pituitary adenomas: difference among various types defined by cytokeratin distribution pattern including a transitional form. Endocrine Pathology 2008 19 82-91. (doi:10.1007/s12022-008-9029-z)
16. Bhayana S, Booth GL, Asa SL, Kovacs K & Ezzat S. The implication of somatotroph adenoma phenotype to somatostatin analog responsiveness in acromegaly. Journal of Clinical Endocrinology and Metabolism 2005 90 6290-6295. (doi:10.1210/jc.2005-0998)
17. Freda PU. Monitoring of acromegaly: what should be performed when GH and IGF-1 levels are discrepant? Clinical Endocrinology 2009 71 166-170. (doi:10.1111/j.1365-2265.2009.03556.x)